Recently, studies from our groups have shown that genetic- [30] or pharmacologic-mediated [31] inhibition of STAT3 at the time of brain injury induced by status epilepticus (SE), reduces the severity of subsequent epilepsy in rodent models. The gene discussed is STAT3; the disease is status epilepticus.